Literature DB >> 27542507

Quantitative body fluid proteomics in medicine - A focus on minimal invasiveness.

Éva Csősz1, Gergő Kalló1, Bernadett Márkus1, Eszter Deák2, Adrienne Csutak3, József Tőzsér4.   

Abstract

Identification of new biomarkers specific for various pathological conditions is an important field in medical sciences. Body fluids have emerging potential in biomarker studies especially those which are continuously available and can be collected by non-invasive means. Changes in the protein composition of body fluids such as tears, saliva, sweat, etc. may provide information on both local and systemic conditions of medical relevance. In this review, our aim is to discuss the quantitative proteomics techniques used in biomarker studies, and to present advances in quantitative body fluid proteomics of non-invasively collectable body fluids with relevance to biomarker identification. The advantages and limitations of the widely used quantitative proteomics techniques are also presented. Based on the reviewed literature, we suggest an ideal pipeline for body fluid analyses aiming at biomarkers discoveries: starting from identification of biomarker candidates by shotgun quantitative proteomics or protein arrays, through verification of potential biomarkers by targeted mass spectrometry, to the antibody-based validation of biomarkers. The importance of body fluids as a rich source of biomarkers is discussed. SIGNIFICANCE: Quantitative proteomics is a challenging part of proteomics applications. The body fluids collected by non-invasive means have high relevance in medicine; they are good sources for biomarkers used in establishing the diagnosis, follow up of disease progression and predicting high risk groups. The review presents the most widely used quantitative proteomics techniques in body fluid analysis and lists the potential biomarkers identified in tears, saliva, sweat, nasal mucus and urine for local and systemic diseases.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AMP; Biomarker; Body fluid; Quantitative proteomics; Targeted proteomics

Mesh:

Substances:

Year:  2016        PMID: 27542507     DOI: 10.1016/j.jprot.2016.08.009

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  21 in total

1.  Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.

Authors:  Isabel Ortuño-Lizarán; Thomas G Beach; Geidy E Serrano; Douglas G Walker; Charles H Adler; Nicolás Cuenca
Journal:  Mov Disord       Date:  2018-05-08       Impact factor: 10.338

2.  SWATH-MS Protocols in Human Diseases.

Authors:  Maria Del Pilar Chantada-Vázquez; María García Vence; Antonio Serna; Cristina Núñez; Susana B Bravo
Journal:  Methods Mol Biol       Date:  2021

3.  Multiplexed Isobaric Tag-Based Profiling of Seven Murine Tissues Following In Vivo Nicotine Treatment Using a Minimalistic Proteomics Strategy.

Authors:  Joao A Paulo; Mark P Jedrychowski; Edward T Chouchani; Lawrence Kazak; Steven P Gygi
Journal:  Proteomics       Date:  2018-05-02       Impact factor: 3.984

Review 4.  Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer.

Authors:  Amrita Mukherjee; Chinmayi Bhagwan Pednekar; Siddhant Sujit Kolke; Megha Kattimani; Subhiksha Duraisamy; Ananya Raghu Burli; Sudeep Gupta; Sanjeeva Srivastava
Journal:  Proteomes       Date:  2022-04-29

5.  Salivary proteomics of healthy dogs: An in depth catalog.

Authors:  Sheila M F Torres; Eva Furrow; Clarissa P Souza; Jennifer L Granick; Ebbing P de Jong; Timothy J Griffin; Xiong Wang
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

6.  Construction and characterization of the Korean whole saliva proteome to determine ethnic differences in human saliva proteome.

Authors:  Ha Ra Cho; Han Sol Kim; Jun Seo Park; Seung Cheol Park; Kwang Pyo Kim; Troy D Wood; Yong Seok Choi
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

7.  Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.

Authors:  Éva Csősz; Péter Lábiscsák; Gergő Kalló; Bernadett Márkus; Miklós Emri; Adrienn Szabó; Ildikó Tar; József Tőzsér; Csongor Kiss; Ildikó Márton
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

Review 8.  Protein-Based Salivary Profiles as Novel Biomarkers for Oral Diseases.

Authors:  Alejandro I Lorenzo-Pouso; Mario Pérez-Sayáns; Susana B Bravo; Pía López-Jornet; María García-Vence; Manuela Alonso-Sampedro; Javier Carballo; Abel García-García
Journal:  Dis Markers       Date:  2018-11-07       Impact factor: 3.434

9.  Proteomic identification of elevated saliva kallikrein levels in the mdx-4cv mouse model of Duchenne muscular dystrophy.

Authors:  Sandra Murphy; Margit Zweyer; Rustam R Mundegar; Dieter Swandulla; Kay Ohlendieck
Journal:  Biochem Biophys Rep       Date:  2018-05-30

10.  Salivary proteome profiling of oral squamous cell carcinoma in a Hungarian population.

Authors:  Éva Csősz; Bernadett Márkus; Zsuzsanna Darula; Katalin F Medzihradszky; Judit Nemes; Emese Szabó; József Tőzsér; Csongor Kiss; Ildikó Márton
Journal:  FEBS Open Bio       Date:  2018-02-19       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.